Generics & Biosimilars | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.
  • AAM All Access Podcast
    Featured AAM All Access Podcast: Mary Beth Powers
    AAM CEO Dan Leonard talks with Mary Beth Powers, President and CEO of AAM Associate Member Catholic Medical Mission Board (CMMB). With its focus on women and children, CMMB provides long-term care and medicines to communities around the world affected by poverty and unequal access to health care.
  • Markup Madness
    Who’s Profiting from Your Prescription?
    Unlike brand drugs where the manufacturer stands to profit the most, generic medicines are often exploited by middlemen that seize significant profits at the expense of patients and the companies that make the medicines.
  • GDUFA/BsUFA User Fees
    What Are GDUFA and BsUFA User Fees?
    Watch this this video to learn more about how the Generic Drug User Fee Amendments (GDUFA) and Biosimilar User Fee Act (BsUFA) help to get more generic and biosimilar medicines to patients more quickly.
    Watch Video
  • Ariel
    AAM Calls on FTC to Investigate PBM Business Practices
    “A distinct set of PBM business practices have resulted in higher prices and delayed access to generics and biosimilars for patients,” said AAM CEO Dan Leonard.
  • 2021 state savings map
    Generic Medicines Are Saving Your State Billions
    In 2020, generic and biosimilar medicines saved America's patients $338 billion. Find out how much your state saved with our interactive savings map.
  • Generics and Biosimilars are the Prescription for State Savings #Rx4StateSavings
    Prescription for State Savings
    State lawmakers can take meaningful action to lower brand prescription drug costs with the Prescription for State Savings. AAM outlines several solutions states could pursue.
  • AAM Voices of Access
    AAM Voices of Access
    Physicians, pharmacists, patients and caregivers across the country trust generics and biosimilars. Here are their stories, in their own words—along with perspectives from health care professionals and the AAM team.

Our Brands and Campaigns

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.